Article

Daurisoline Suppresses Growth of Esophageal Squamous Cell Carcinoma by Inhibiting MEK1/2 In Vitro and In Vivo

2021-05-07

Abstract excerpt

<h4>Background: </h4> Esophageal squamous cell carcinoma (ESCC) accounts for 90% of esophageal cancer and has a high mortality rate worldwide. The clinical treatment of ESCC is mainly surgical resection. The five-year survival rate of ESCC patients in developing countries is less than 20%. Therefore, identifying new and effective drugs that can prevent the occurrence and recurrence of ESCC is clinically significan...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5b0e3b9e-29cb-5cb4-8399-cc4b4303d5f8
DOI: 10.21203/rs.3.rs-416241/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Daurisoline Suppresses Growth of Esophageal Squamous Cell Carcinoma by Inhibiting MEK1/2 In Vitro and In VivoDOI 10.21203/rs.3.rs-416241/v1Read

Benzydamine, a CDK2 Kinase Inhibitor, Suppresses The Growth of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.Semantic proximity Read

Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma.Semantic proximity Read

Repurposing proteasome inhibitors in the treatment of esophageal squamous cell cancerSemantic proximity Read

Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinomaSemantic proximity Read

NEK2 Promotes the Migration, Invasion, Proliferation and Drug Resistance of ESCC Through the E2F1-IGF2 PathwaySemantic proximity Read

Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell CarcinomaSemantic proximity Read

Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathwaySemantic proximity Read

Anlotinib inhibits the development of esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathwaySemantic proximity Read

HK2 promotes malignant progression of esophageal squamous carcinoma by mediating VDAC1 resistance to mitochondrial apoptosisSemantic proximity Read

Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.Semantic proximity Read

The miR-19b-3p/MAP2K3/STAT3 Feedback Loop Regulates Cell Proliferation and Invasion in Esophageal Squamous Cell CarcinomaSemantic proximity Read

Small Molecule Screen Identifies Pyrimethamine as an Inhibitor of NRF2-driven Esophageal HyperplasiaSemantic proximity Read